Dr.Malwinder

Dr.Malwinder π“π‘πž 𝐁𝐚π₯𝐝 𝐎𝐧𝐜𝐨π₯𝐨𝐠𝐒𝐬𝐭

Every tumour has its own biological fingerprint and understanding it can help guide more precise treatment decisions.Nex...
11/08/2026

Every tumour has its own biological fingerprint and understanding it can help guide more precise treatment decisions.

Next-Generation Sequencing (NGS) allows us to look deeper into the genetic profile of a cancer and identify potential targeted treatment options.

The question is: Could NGS be relevant for your cancer?

Speak to your oncologist to find out.

10/08/2026

Kanser tak berjangkit… tapi stigma boleh melukakan.

Di sebalik setiap rawatan, ada jiwa yang sedang berjuang. Bukan sahaja bertarung dengan kesakitan fizikal, tetapi juga rasa tersisih apabila orang sekeliling mula menjauhkan diri kerana ketakutan yang tidak berasas.

Kanser bukan penyakit berjangkit. Ia tidak akan merebak melalui pelukan, senyuman, mahupun cawan atau sudu yang dikongsi.

Apa yang mereka perlukan bukanlah cawan pakai buang atau bilik air berasingan… tetapi sokongan, penerimaan dan kasih sayang daripada insan tersayang.

Mari kita hentikan stigma dan sebarkan kasih sayang. 🀍

07/08/2026

Kanser payudara peringkat 4 bukan sahaja membawa cabaran dari segi penyakit, tetapi juga kesan terhadap kualiti hidup. Bagi sesetengah pesakit, luka yang berdarah, berbau atau sukar sembuh boleh menyebabkan kesakitan, ketidakselesaan dan menjejaskan keyakinan diri.
Melalui rawatan radioterapi paliatif, matlamatnya bukan semata-mata untuk mengecilkan tumor, tetapi juga membantu mengawal pendarahan, memperbaiki keadaan luka, dan mengurangkan keperluan penjagaan luka setiap hari.

Teknologi radioterapi terkini seperti sistem ETHOS berjaya membantu seorang pesakit selepas hanya 5 sesi rawatan mengurangkan saiz tumor, mengawal pendarahan, dan memperbaiki keadaan kulit di kawasan yang terjejas. Hasilnya, pesakit dapat menjalani rutin harian dengan lebih selesa dan bermaruah.

Setiap pesakit mempunyai perjalanan yang berbeza. Berbincanglah dengan doktor pakar anda untuk mengetahui pilihan rawatan yang paling sesuai berdasarkan keadaan klinikal anda.

06/08/2026

A moment to celebrate, but more importantly, a reminder of why I do what I do

It is a true honour to receive the Healthcare Influencer Recognition (Advancing Excellence in Oncology) at The BrandLaureate Medical & Healthcare Advancement BestBrands Awards 2026.

This recognition belongs to every patient who has trusted me, every family who has let me into their journey, and everyone who tunes in to learn and advocate for cancer awareness.

Special thanks to Brandstorm Asia and DocTok Asia for partnering with us to keep healthcare content ethical, evidence-based, and patient-first. When purpose leads, trust follows.

Thank you to The BrandLaureate for this incredible platform, and to my team, colleagues, and family for the unwavering support.

Here’s to making cancer education more accessible and touching lives, one conversation at a time. ❀️

Delighted to have chaired the Meet-the-Expert session with Prof. Heinz-Josef Lenz, where we explored the evolving role o...
04/08/2026

Delighted to have chaired the Meet-the-Expert session with Prof. Heinz-Josef Lenz, where we explored the evolving role of immunotherapy across gastrointestinal malignancies. Grateful for the insightful discussions and the opportunity to learn from one of the leading minds in oncology

πŸ† It is a true honour to be recognised at The BrandLaureate Medical & Healthcare Advancement BestBrands Awards 2026, rec...
03/08/2026

πŸ† It is a true honour to be recognised at The BrandLaureate Medical & Healthcare Advancement BestBrands Awards 2026, receiving the Healthcare Influencer recognition under the category of Advancing Excellence in Oncology.

This recognition is far bigger than me. It belongs to every patient who has placed their trust in me, every family who has allowed me to be part of their journey, and everyone who has taken the time to learn more about cancer through the conversations and educational content we share.

To my family, colleagues, and the incredible healthcare professionals I have the privilege of working alongside, thank you for your dedication, encouragement, and commitment to improving lives.

A heartfelt thank you to Brandstorm Asia, together with Doctok Asia as the official media partner, for believing in the importance of ethical, evidence-based healthcare communication. Our shared commitment to creating accurate, responsible, and patient-first content has helped make cancer education more accessible to the community. Partnerships built on purpose don’t just amplify messages, they build trust.

To the BrandLaureate team, thank you for this meaningful recognition and for creating a platform that celebrates excellence across Malaysia’s healthcare landscape. It is a privilege to be recognised among so many individuals and organisations committed to making a difference.

This recognition strengthens my commitment to continue educating with integrity, advocating for better cancer awareness, and serving the community with purpose.

Here’s to touching more lives, one conversation at a time.

01/08/2026

The truth about immunotherapy isn't what social media makes it seem.

Because cancer isn't one disease and immunotherapy isn't a one-size-fits-all treatment.

The internet loves simple answers. Cancer treatment isn't one of them.

In this video, I explain why immunotherapy can be life-changing for some patients, yet completely ineffective for others, and why the right treatment always starts with the right diagnosis.

Don't let viral content make your treatment decisions.

Watch this before you believe the next "miracle cure" you see online.

An insightful couple of days at the 4th Leading Cancer Care Summit in Bangkok! πŸ‡ΉπŸ‡­Engaged in incredible discussions on pr...
22/07/2026

An insightful couple of days at the 4th Leading Cancer Care Summit in Bangkok! πŸ‡ΉπŸ‡­

Engaged in incredible discussions on precision oncology, from navigating real-world ADC challenges to leveraging multi-omics in clinical decision-making. Grateful to connect with fellow experts dedicated to elevating the standard of cancer care.

20/07/2026

Tak semua kanser payudara memerlukan pembuangan keseluruhan payudara.

Dengan kemajuan rawatan moden, sesetengah pesakit mungkin layak menjalani Breast Conserving Surgery (BCS), iaitu membuang ketumbuhan sambil mengekalkan sebanyak mungkin tisu payudara yang sihat. Namun, bagi kes tertentu, mastectomy masih merupakan pilihan rawatan yang paling sesuai.

Keputusan ini bergantung kepada beberapa faktor seperti saiz dan lokasi tumor, tahap penyakit, biologi kanser, serta keadaan individu pesakit. Sebab itu, setiap pelan rawatan adalah berbeza dan perlu dibincangkan secara menyeluruh bersama pakar.

Tonton video ini untuk memahami perbezaan antara kedua-dua prosedur dan mengapa rawatan setiap pesakit tidak semestinya sama.

18/07/2026

Kenapa Tak Boleh Terus Bedah?

Ramai pesakit bertanya, β€œDoktor, kenapa tak boleh terus buang tumor?”

Jawapannya bergantung pada biologi kanser.

βœ… Kurang agresif: Pembedahan boleh dilakukan terlebih dahulu.

⚠️ Lebih agresif (HER2-positif, Triple-Negative atau tumor besar): Rawatan seperti kemoterapi, targeted therapy atau immunotherapy perlu dimulakan sebelum pembedahan (terapi neoadjuvan).

Ini bertujuan merawat sel-sel kanser mikroskopik yang mungkin sudah berada di dalam badan tetapi belum dapat dikesan.

Rawatan yang betul bukan sekadar membuang tumor, tetapi merawat keseluruhan penyakit.

Address

Bangsar
Kuala Lumpur
59100

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00
Saturday 09:00 - 13:00

Telephone

+601159963508

Website

Alerts

Be the first to know and let us send you an email when Dr.Malwinder posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category